CAS RN: 1262129-47-4
Dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin, 4-hydroxy-2,6-bis(10-phenyl-9-anthracenyl)-, 4-oxide, (11bR)-
Product Availability
Choose a grade to view its available package options.
6 package records6 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250906 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250508 |
100mg / 250mg |
Confirm by inquiry |
Shanghai | Inquiry |
| Batchno.20250216 |
1g |
In stock |
Shanghai | Inquiry |
| Batchno.20260202 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250630 |
25mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250623 |
50mg |
In stock |
Shanghai, Tianjin | Inquiry |
-
Product code:
starshine_CAS1262129-47-4
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1262129-47-4 / 13-hydroxy-10,16-bis(10-phenylanthracen-9-yl)-12,14-dioxa-13lambda5-phosphapentacyclo[13.8.0.02,11.03,8.018,23]tricosa-1(15),2(11),3,5,7,9,16,18,20,22-decaene 13-oxide
Standard CAS: 1262129-47-4
Multi CAS: No
Basic Information
CAS
1262129-47-4
Multi CAS
No
Molecular Formula
C60H37O4P
Molecular Weight
852.900000
Exact Mass
852.242947
SMILES
C1=CC=C(C=C1)C2=C3C=CC=CC3=C(C4=CC=CC=C42)C5=CC6=CC=CC=C6C7=C5OP(=O)(OC8=C7C9=CC=CC=C9C=C8C1=C2C=CC=CC2=C(C2=CC=CC=C21)C1=CC=CC=C1)O
InChI
InChI=1S/C60H37O4P/c61-65(62)63-59-51(55-47-31-15-11-27-43(47)53(37-19-3-1-4-20-37)44-28-12-16-32-48(44)55)35-39-23-7-9-25-41(39)57(59)58-42-26-10-8-24-40(42)36-52(60(58)64-65)56-49-33-17-13-29-45(49)54(38-21-5-2-6-22-38)46-30-14-18-34-50(46)56/h1-36H,(H,61,62)
InChIKey
ALIMLQCMVDKKHP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
65
Aromatic heavy atom count
60
Rotatable bonds
4
H-bond acceptors
3
H-bond donors
1
Molar refractivity
269.74
TPSA
55.76
LogP / Solubility
WLOGP
16.81
MLOGP
14.87
XLogP3
16.3
Consensus LogP
15.99
Log S (ESOL)
-16.14
Class (ESOL)
Insoluble
Log S (Ali)
-18.69
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-19.64
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
4.01
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9